Altamira Therapeutics Ltd (NQ: CYTO )
1.480
-0.010
(-0.67%)
Streaming Delayed Price
Updated: 11:54 AM EDT, May 21, 2024
Add to My Watchlist
All News about Altamira Therapeutics Ltd
Altamira Therapeutics Announces Reverse Stock Split
October 24, 2022
Via GlobeNewswire
Altamira Therapeutics to Participate at RNA Leaders USA Congress
October 13, 2022
Via GlobeNewswire
Via GlobeNewswire
Via Benzinga
Altamira Therapeutics Receives FDA 510(k) Clearance for Bentrio to Treat Allergic Rhinitis
June 27, 2022
Via AccessWire
Exposures
Product Safety
Altamira Therapeutics Achieves COVAMID Trial Target Enrollment for Bentrio in Acute COVID-19
June 23, 2022
Via AccessWire
Exposures
COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|